Identification of a Contact Domain between Echistatin and the Integrin αvβ3by Photoaffinity Cross-Linking
- 22 November 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 40 (50) , 15117-15126
- https://doi.org/10.1021/bi0109156
Abstract
The integrin αvβ3 is the major receptor mediating the attachment of osteoclasts to the extracellular matrix in bone and plays a critical role in bone resorption and bone remodeling. Most of the ligands interacting with the αvβ3 receptor contain an Arg-Gly-Asp (RGD) motif. Recently, we have identified two small RGD peptides, containing a benzophenone moiety at either the carboxyl or amino terminus, that photo-cross-linked within the β3[99−118] [Bitan, G., et al. (1999) Biochemistry38, 3414−3420] or the β3[167−171] [Bitan, G., et al. (2000) Biochemistry39, 11014−11023] sequence, respectively, of the αvβ3 receptor in a selective fashion. Here, we report the synthesis of a photoreactive analogue of echistatin (a 49-amino acid peptide), a potent RGD-containing antagonist of the αvβ3 receptor both in vitro and in vivo. This bioactive analogue is substituted at position 45 with a p-benzoyl moiety (pBz2), located within the flexible C-terminal domain and removed 20 amino acid residues from the R24GD26 triad. This C-terminal domain was reported to contribute to receptor binding affinity by acting as an auxiliary binding site. The radiolabeled 125I-[Arg35,Lys45(Nε-pBz2)]-echistatin photo-cross-links effectively to a site within the β3[209−220] sequence. Residues in this domain have been reported to be part of the metal ion-dependent adhesion site (MIDAS). Receptor fragments overlapping this domain were reported to bind to fibrinogen and block fibrinogen binding to αIIbβ3, the platelet integrin receptor. Taken together, position 45 in echistatin, located within an auxiliary binding site in echistatin, cross-links to a site distinct from the two previously reported sites, β3[99−118] and β3[167−171], which cross-link to photophores flanking the RGD triad. These cross-linking data support the hypothesis that the ligand-bound conformation of the integrin β3 subunit differs from the known conformation of I domains.Keywords
This publication has 23 references indexed in Scilit:
- An Isoleucine-based Allosteric Switch Controls Affinity and Shape Shifting in Integrin CD11b A-domainJournal of Biological Chemistry, 2000
- Emerging therapies for osteoporosisEmerging Drugs, 2000
- A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.Journal of Clinical Investigation, 1997
- A structure prediction for the ligand‐binding region of the integrin β subunit: evidence for the presence of a von Willebrand factor A domainFEBS Letters, 1997
- Ligand Binding to Integrin αIIbβ3 Is Dependent on a MIDAS-like Domain in the β3 SubunitPublished by Elsevier ,1996
- Activation of the Integrin αvβ3 Involves a Discrete Cation-binding Site That Regulates ConformationPublished by Elsevier ,1996
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface.The Journal of cell biology, 1991
- Localization of an Arg-Gly-Asp Recognition Site Within an Integrin Adhesion ReceptorScience, 1988
- A general strategy for elaboration of the dithiocarbonyl functionality, -(C:O)SS-: application to the synthesis of bis(chlorocarbonyl)disulfane and related derivatives of thiocarbonic acidsThe Journal of Organic Chemistry, 1983